
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1042 | 1042 | 1009 | 1028 | 1538 | 1944 |
Fund Return | 4.16% | 4.16% | 0.86% | 0.91% | 8.99% | 6.87% |
Place in category | 652 | 652 | 646 | 464 | 80 | 34 |
% in Category | 89 | 89 | 93 | 81 | 18 | 12 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
B Multistock Swiss Stock Fund CHF B | 98.76M | 4.16 | 0.91 | 6.87 | ||
B Multistock Swiss Stock Fund CHF C | 12.92M | 4.36 | 1.67 | 7.67 | ||
Multiflex S Carnot Efficient Energc | 85.45M | -0.86 | -1.98 | 2.72 | ||
Popso Suisse Investment Fund S Glob | 89.66M | 2.76 | 0.94 | 1.50 | ||
S CEAMS Quality Switzerland Equityb | 51.62M | 4.09 | -6.57 | 4.90 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.34B | 9.97 | 4.26 | 6.64 | ||
Pictet CH Institutional Swiss EquiZ | 1.91B | 8.90 | 2.54 | 8.57 | ||
Pictet CH Institutional Swiss EquiI | 1.91B | 6.32 | 1.38 | 6.61 | ||
Pictet CH Institutional Swiss EquZD | 1.91B | 6.45 | 1.86 | 7.11 | ||
Pictet CH Institutional Swiss EquiP | 1.91B | 6.27 | 1.17 | 6.39 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 8.45 | 88.74 | +3.08% | |
Roche Holding Participation | CH0012032048 | 5.72 | 251.70 | +3.24% | |
ABB | CH0012221716 | 5.20 | 41.37 | +2.73% | |
Nestle | CH0038863350 | 5.05 | 86.05 | +1.26% | |
Holcim | CH0012214059 | 4.98 | 86.46 | +2.56% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review